Fig. 1. Antibody-drug conjugate structure consisting of monoclonal antibody, linker, and cytotoxic payload. The antibody is specific to tumor cell surface proteins. The linker is the chemical connector that binds the drug to the antibody. The payload is a highly potent cytotoxic drug. Fab, fragment antigen binding; Fc, fragment crystallizable.
